1-Boc-4-氨基吲哚 | 885270-30-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-Boc-4-氨基吲哚
• 中文别名: 1-BOC-4-氨基吲哚
• 英文名称: tert-butyl 4-amino-1H-indole-1-carboxylate
• 英文别名: 1-Boc-4-aminoindole；tert-butyl 4-aminoindole-1-carboxylate
• CAS: 885270-30-4
• 化学式: C₁₃H₁₆N₂O₂
• 分子量: 232.282
• InChiKey: OKLWIGZVXJTALB-UHFFFAOYSA-N

物化性质

• 沸点：
  384.2±34.0 °C(Predicted)
• 密度：
  1.16±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Boc-4-aminoindole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Boc-4-aminoindole
CAS number: 885270-30-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H16N2O2
Molecular weight: 232.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-Boc-4-氨基吲哚 在 N-氯代丁二酰亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以15%的产率得到tert-butyl 4-amino-5-chloro-1H-indole-1-carboxylate
  参考文献：
  名称：

  [EN] COMPOUNDS AND THEIR USE IN TREATING CANCER
  [FR] COMPOSÉS ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER

  摘要：

  本规范一般涉及到公式（I）的化合物及其药学上可接受的盐，其中A、Z、Y、RA、连接剂和v具有本规范中定义的任何含义。本规范还涉及使用这些化合物及其药学上可接受的盐在治疗人或动物体内的方法中，例如在预防或治疗癌症方面的应用。本规范还涉及到准备这些化合物所涉及的过程和中间体化合物，以及含有它们的制药组合物。

  公开号：

  WO2022069520A1
• 作为产物：
  描述：

  1-叔丁氧羰基-4-硝基吲哚 在 铁粉 、 氯化铵 作用下， 以 水 、 异丙醇 为溶剂， 以3.12 g的产率得到1-Boc-4-氨基吲哚
  参考文献：
  名称：

  4-异氰基吲哚-2ʹ-脱氧核糖核苷 （4ICIN）：一种同构吲哚核苷，适用于反电子需求 Diels-Alder 反应

  摘要：

  同构核苷是研究涉及核苷和核酸的各种生物过程的强大工具化合物。我们之前报道了一种称为 4CIN 的荧光同构吲哚核苷。4CIN 的一个显着分子特征是在吲哚上存在一个 4-氰基部分，其作用是核碱基。鉴于已知的异腈与 [4+1] -环加成化学反应性与四嗪的化学反应性，我们研究了 4CIN 转化为相应的异腈是否会赋予有用的化学探针。在这里，我们报道了 4-异氰基吲哚-2ʹ-脱氧核糖核糖核苷 （4ICIN） 的合成以及 4ICIN 与模型四嗪进行逆电子需求 Diels-Alder 环加成反应的倾向。

  DOI：

  10.1016/j.tetlet.2023.154807

文献信息

• 7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS
  申请人：Venkatesan Aranapakam Mudumbai

  公开号：US20090227575A1

  公开（公告）日：2009-09-10

  A 7H-pyrrolo[2,3-h]quinazoline compound of the formula I wherein Ar, R 1 , R 2 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , and n are as defined in the specification, and methods for making same.

  一个7H-吡咯[2,3-h]喹唑啉化合物的公式I 其中Ar，R1，R2，R7，R8，R9，R10，R11，R12和n如说明书中所定义，以及制造相同的方法。
• Ligand-Promoted <i>Meta</i>-C–H Arylation of Anilines, Phenols, and Heterocycles
  作者：Peng Wang、Marcus E. Farmer、Xing Huo、Pankaj Jain、Peng-Xiang Shen、Mette Ishoey、James E. Bradner、Steven R. Wisniewski、Martin D. Eastgate、Jin-Quan Yu

  DOI：10.1021/jacs.6b04966

  日期：2016.7.27

  Here we report the development of a versatile 3-acetylamino-2-hydroxypyridine class of ligands that promote meta-C-H arylation of anilines, heterocyclic aromatic amines, phenols, and 2-benzyl heterocycles using norbornene as a transient mediator. More than 120 examples are presented, demonstrating this ligand scaffold enables a wide substrate and coupling partner scope. Meta-C-H arylation with heterocyclic

  在这里，我们报告了一种通用的 3-乙酰氨基-2-羟基吡啶类配体的开发，这些配体使用降冰片烯作为瞬态介质促进苯胺、杂环芳香胺、苯酚和 2-苄基杂环的间位 CH 芳基化。提供了 120 多个例子，证明了这种配体支架能够实现广泛的底物和偶联伙伴范围。使用该配体还首次实现了以杂环芳基碘化物作为偶联伙伴的间位 CH 芳基化。通过允许来那度胺衍生物的间位 CH 芳基化，展示了这种药物发现转化的效用。还展示了该反应的无银方案的第一步。
• 말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도
  申请人：KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 한국과학기술연구원(319980077518) BRN ▼209-82-03522

  公开号：KR20200076655A

  公开（公告）日：2020-06-29

  본 발명은 말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체(hydrazone derivatives) 및 이의 용도에 관한 것이다.

  这项发明涉及末端氨基被芳基或杂芳基取代的新的腙衍生物(hydrazone derivatives)及其用途。
• Chemoselective N-Acylation of Indoles and Oxazolidinones with Carbonylazoles
  作者：Stephen T. Heller、Erica E. Schultz、Richmond Sarpong

  DOI：10.1002/anie.201203976

  日期：2012.8.13

  Unique reactivity: In the presence of more reactive amine and alcohol functional groups and of carboxylic acids, the chemoselective N‐acylation of indoles (see scheme) and oxazolidinones is achieved by taking advantage of the unique reactivity of carbonylazole acylating agents with catalytic amounts of 1,8‐diazabicyclo[5.4.0]undec‐7‐ene (DBU).

  独特的反应性：在存在更多的反应性胺和醇官能团以及羧酸的情况下，吲哚和恶唑烷酮的化学选择性N-酰化是通过利用催化量为1的羰基唑酰化剂的独特反应性来实现的，8-二氮杂双环[5.4.0]十一月-7-烯（DBU）。
• Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase
  作者：Yuta Tanaka、Osamu Kurasawa、Akihiro Yokota、Michael G. Klein、Koji Ono、Bunnai Saito、Shigemitsu Matsumoto、Masanori Okaniwa、Geza Ambrus-Aikelin、Daisuke Morishita、Satoshi Kitazawa、Noriko Uchiyama、Kazumasa Ogawa、Hiromichi Kimura、Shinichi Imamura

  DOI：10.1021/acs.jmedchem.9b01979

  日期：2020.3.26

  Therefore, inhibition of DHPS is a promising therapeutic option for the treatment of cancer. To discover novel lead compounds that target DHPS, we conducted synthetic studies with a hit obtained via high-throughput screening. Optimization of the ring structures of the amide compound (2) led to bromobenzothiophene (11g) with potent inhibitory activity against DHPS. X-ray crystallographic analysis of

  脱氧苏氨酸合酶（DHPS）利用亚精胺和NAD作为辅因子，将苏氨酸修饰整合到真核翻译起始因子5A（eIF5A）中。酪氨酸对于eIF5A激活至关重要，而eIF5A激活则在调节与癌蛋白合成相关的所选mRNA的蛋白质翻译中起关键作用，从而增强肿瘤细胞的增殖。因此，抑制DHPS是用于癌症治疗的有前途的治疗选择。为了发现针对DHPS的新型先导化合物，我们进行了合成研究，并通过高通量筛选获得了成功。优化酰胺化合物（2）的环结构可生成溴苯并噻吩（11g）具有对DHPS的有效抑制活性。对11g与DHPS配合的X射线晶体学分析表明DHPS发生了显着的构象变化，表明存在新的变构位点。这些发现为开发不同于亚精胺模拟抑制剂的新疗法提供了基础。